North America Microbiome Diagnostics Market Size, Share & Trends Analysis Report By Application, By Product, By Sample, By Technology, By End User, By Country and Growth Forecast, 2023

List of Tables

The North America Microbiome Diagnostics Market would witness market growth of 16.9% CAGR during the forecast period (2023-2030).

The US market dominated the North America Microbiome Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $157,641.6 Thousands by 2030. The Canada market is exhibiting a CAGR of 19.5% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 19.1% during (2023 - 2030).

It is increasingly integrated into clinical practice, particularly in gastroenterology, oncology, immunology, dermatology, and women's health. Clinicians utilize microbiome diagnostics to aid in disease diagnosis, risk assessment, treatment selection, and monitoring of therapeutic responses. For example, in gastroenterology, it helps identify microbial biomarkers associated with inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and colorectal cancer, guiding personalized treatment strategies and dietary interventions. In dermatology, it is used to study the skin microbiome and its role in dermatological conditions such as acne, eczema, and psoriasis, informing skincare interventions and therapeutic approaches. The adoption of microbiome diagnostics in clinical settings is driven by the need for more precise and personalized healthcare solutions tailored to individual patient characteristics and microbial profiles.

Additionally, it is widely utilized in research laboratories to investigate microbiome-host interactions, disease mechanisms, and therapeutic targets. Academic institutions, biotechnology companies, and pharmaceutical firms invest in microbiome research initiatives, leveraging microbiome diagnostics to drive innovation in drug discovery, biomarker identification, and therapeutic development. Researchers utilize microbiome diagnostics to study microbial communities' composition, diversity, and function in various disease states, environmental contexts, and experimental models. It enables researchers to unravel the complex relationships between microbial communities and host physiology, paving the way for discoveries and breakthroughs in microbiome research.

Mexico's pharmaceutical sector's growth can provide financial resources and infrastructure support for clinical trials and research initiatives focused on microbiome-based interventions. The pharmaceutical sector in Mexico is divided into patented medicines, which represent 51 percent of the market by value, generics, which represent 35 percent, and over-the-counter products, which represent the remaining 14 percent. As the pharmaceutical sector expands in Mexico, there may be a growing interest in microbiome-based therapeutics for various diseases and conditions. Hence, the increasing investments in the healthcare sector and the rising pharmaceutical industry in the region are propelling the market's growth.

Based on Application, the market is segmented into Disease Diagnostics (Gastrointestinal Disorders, Metabolic Diseases and Others) and Research Application. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Sample, the market is segmented into Fecal, Saliva, Skin, and Others. Based on Technology, the market is segmented into 16S rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics and Others. Based on End User, the market is segmented into Hospitals, Academic & Research Institutes, and Biotechnology & Pharmaceutical Companies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Illumina, Inc.
Becton, Dickinson and Company
Genetic Analysis AS
Microba Life Sciences Limited
BioMe Oxford Ltd
Viome Life Sciences, Inc.
GoodGut S.L.U. (HIPRA, S.A.)
Sun Genomics
Origin Sciences Limited
Decode Age

North America Microbiome Diagnostics Market Report Segmentation

By Application

Disease Diagnostics
- Gastrointestinal Disorders
- Metabolic Diseases
- Others
Research Application

By Product

Reagents & Kits
Instruments

By Sample

Fecal
Saliva
Skin
Others

By Technology

16S rRNA Sequencing
Shot Gun Metagenomics
Metatranscriptomics
Others

By End User

Hospitals
Academic & Research Institutes
Biotechnology & Pharmaceutical Companies

By Country

US
Canada
Mexico
Rest of North America

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1North America Microbiome Diagnostics Market, by Application
- 1.4.2North America Microbiome Diagnostics Market, by Product
- 1.4.3North America Microbiome Diagnostics Market, by Sample
- 1.4.4North America Microbiome Diagnostics Market, by Technology
- 1.4.5North America Microbiome Diagnostics Market, by End User
- 1.4.6North America Microbiome Diagnostics Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
3.3Porter Five Forces Analysis

Chapter 4.Strategies Deployed in Microbiome Diagnostics Market

Chapter 5.North America Microbiome Diagnostics Market by Application

5.1North America Disease Diagnostics Market by Region
5.2North America Microbiome Diagnostics Market by Disease Diagnostics Type
- 5.2.1North America Gastrointestinal Disorders Market by Country
- 5.2.2North America Metabolic Diseases Market by Country
- 5.2.3North America Others Market by Country
5.3North America Research Application Market by Region

Chapter 6.North America Microbiome Diagnostics Market by Product

6.1North America Reagents & Kits Market by Country
6.2North America Instruments Market by Country

Chapter 7.North America Microbiome Diagnostics Market by Sample

7.1North America Fecal Market by Country
7.2North America Saliva Market by Country
7.3North America Skin Market by Country
7.4North America Others Market by Country

Chapter 8.North America Microbiome Diagnostics Market by Technology

8.1North America 16S rRNA Sequencing Market by Country
8.2North America Shot Gun Metagenomics Market by Country
8.3North America Metatranscriptomics Market by Country
8.4North America Others Market by Country

Chapter 9.North America Microbiome Diagnostics Market by End User

9.1North America Hospitals Market by Country
9.2North America Academic & Research Institutes Market by Country
9.3North America Biotechnology & Pharmaceutical Companies Market by Country

Chapter 10.North America Microbiome Diagnostics Market by Country

10.1US Microbiome Diagnostics Market
- 10.1.1US Microbiome Diagnostics Market by Application
  - 10.1.1.1US Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.1.2US Microbiome Diagnostics Market by Product
- 10.1.3US Microbiome Diagnostics Market by Sample
- 10.1.4US Microbiome Diagnostics Market by Technology
- 10.1.5US Microbiome Diagnostics Market by End User
10.2Canada Microbiome Diagnostics Market
- 10.2.1Canada Microbiome Diagnostics Market by Application
  - 10.2.1.1Canada Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.2.2Canada Microbiome Diagnostics Market by Product
- 10.2.3Canada Microbiome Diagnostics Market by Sample
- 10.2.4Canada Microbiome Diagnostics Market by Technology
- 10.2.5Canada Microbiome Diagnostics Market by End User
10.3Mexico Microbiome Diagnostics Market
- 10.3.1Mexico Microbiome Diagnostics Market by Application
  - 10.3.1.1Mexico Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.3.2Mexico Microbiome Diagnostics Market by Product
- 10.3.3Mexico Microbiome Diagnostics Market by Sample
- 10.3.4Mexico Microbiome Diagnostics Market by Technology
- 10.3.5Mexico Microbiome Diagnostics Market by End User
10.4Rest of North America Microbiome Diagnostics Market
- 10.4.1Rest of North America Microbiome Diagnostics Market by Application
  - 10.4.1.1Rest of North America Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.4.2Rest of North America Microbiome Diagnostics Market by Product
- 10.4.3Rest of North America Microbiome Diagnostics Market by Sample
- 10.4.4Rest of North America Microbiome Diagnostics Market by Technology
- 10.4.5Rest of North America Microbiome Diagnostics Market by End User

Chapter 11.Company Profiles

11.1Illumina, Inc.
- 11.1.1Company Overview
- 11.1.2Financial Analysis
- 11.1.3Regional Analysis
- 11.1.4Research & Development Expense
- 11.1.5Recent strategies and developments:
  - 11.1.5.1Partnerships, Collaborations, and Agreements:
- 11.1.6SWOT Analysis
11.2Becton, Dickinson, and Company
- 11.2.1Company Overview
- 11.2.2Financial Analysis
- 11.2.3Segmental and Regional Analysis
- 11.2.4Research & Development Expense
- 11.2.5Recent strategies and developments:
  - 11.2.5.1Product Launches and Product Expansions:
  - 11.2.5.2Trails and Approvals:
- 11.2.6SWOT Analysis
11.3Genetic Analysis AS
- 11.3.1Company Overview
- 11.3.2Financial Analysis
- 11.3.3Regional Analysis
- 11.3.4Recent strategies and developments:
  - 11.3.4.1Partnerships, Collaborations, and Agreements:
11.4Microba Life Sciences Limited
- 11.4.1Company Overview
- 11.4.2Financial Analysis
- 11.4.3Regional Analysis
- 11.4.4Research & Development Expenses
- 11.4.5Recent strategies and developments:
  - 11.4.5.1Partnerships, Collaborations, and Agreements:
  - 11.4.5.2Product Launches and Product Expansions:
11.5BioMe Oxford Ltd
- 11.5.1Company Overview
- 11.5.2Recent strategies and developments:
  - 11.5.2.1Partnerships, Collaborations, and Agreements:
11.6Viome Life Sciences, Inc.
- 11.6.1Company Overview
- 11.6.2Recent strategies and developments:
  - 11.6.2.1Product Launches and Product Expansions:
  - 11.6.2.2Acquisition and Mergers:
11.7GoodGut S.L.U. (HIPRA, S.A.)
- 11.7.1Company Overview
11.8Sun Genomics
- 11.8.1Company Overview
11.9Origin Sciences Limited
- 11.9.1Company Overview
11.10.Decode Age
- 11.10.1Company Overview

LIST OF TABLES

TABLE 1North America Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 2North America Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 3North America Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 4North America Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 5North America Disease Diagnostics Market by Region, 2019 - 2022, USD Thousands
TABLE 6North America Disease Diagnostics Market by Region, 2023 - 2030, USD Thousands
TABLE 7North America Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 8North America Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 9North America Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Thousands
TABLE 10North America Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Thousands
TABLE 11North America Metabolic Diseases Market by Country, 2019 - 2022, USD Thousands
TABLE 12North America Metabolic Diseases Market by Country, 2023 - 2030, USD Thousands
TABLE 13North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 14North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 15North America Research Application Market by Region, 2019 - 2022, USD Thousands
TABLE 16North America Research Application Market by Region, 2023 - 2030, USD Thousands
TABLE 17North America Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 18North America Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 19North America Reagents & Kits Market by Country, 2019 - 2022, USD Thousands
TABLE 20North America Reagents & Kits Market by Country, 2023 - 2030, USD Thousands
TABLE 21North America Instruments Market by Country, 2019 - 2022, USD Thousands
TABLE 22North America Instruments Market by Country, 2023 - 2030, USD Thousands
TABLE 23North America Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 24North America Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 25North America Fecal Market by Country, 2019 - 2022, USD Thousands
TABLE 26North America Fecal Market by Country, 2023 - 2030, USD Thousands
TABLE 27North America Saliva Market by Country, 2019 - 2022, USD Thousands
TABLE 28North America Saliva Market by Country, 2023 - 2030, USD Thousands
TABLE 29North America Skin Market by Country, 2019 - 2022, USD Thousands
TABLE 30North America Skin Market by Country, 2023 - 2030, USD Thousands
TABLE 31North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 32North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 33North America Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 34North America Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 35North America 16S rRNA Sequencing Market by Country, 2019 - 2022, USD Thousands
TABLE 36North America 16S rRNA Sequencing Market by Country, 2023 - 2030, USD Thousands
TABLE 37North America Shot Gun Metagenomics Market by Country, 2019 - 2022, USD Thousands
TABLE 38North America Shot Gun Metagenomics Market by Country, 2023 - 2030, USD Thousands
TABLE 39North America Metatranscriptomics Market by Country, 2019 - 2022, USD Thousands
TABLE 40North America Metatranscriptomics Market by Country, 2023 - 2030, USD Thousands
TABLE 41North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 42North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 43North America Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 44North America Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 45North America Hospitals Market by Country, 2019 - 2022, USD Thousands
TABLE 46North America Hospitals Market by Country, 2023 - 2030, USD Thousands
TABLE 47North America Academic & Research Institutes Market by Country, 2019 - 2022, USD Thousands
TABLE 48North America Academic & Research Institutes Market by Country, 2023 - 2030, USD Thousands
TABLE 49North America Biotechnology & Pharmaceutical Companies Market by Country, 2019 - 2022, USD Thousands
TABLE 50North America Biotechnology & Pharmaceutical Companies Market by Country, 2023 - 2030, USD Thousands
TABLE 51North America Microbiome Diagnostics Market by Country, 2019 - 2022, USD Thousands
TABLE 52North America Microbiome Diagnostics Market by Country, 2023 - 2030, USD Thousands
TABLE 53US Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 54US Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 55US Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 56US Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 57US Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 58US Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 59US Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 60US Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 61US Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 62US Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 63US Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 64US Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 65US Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 66US Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 67Canada Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 68Canada Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 69Canada Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 70Canada Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 71Canada Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 72Canada Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 73Canada Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 74Canada Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 75Canada Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 76Canada Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 77Canada Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 78Canada Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 79Canada Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 80Canada Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 81Mexico Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 82Mexico Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 83Mexico Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 84Mexico Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 85Mexico Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 86Mexico Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 87Mexico Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 88Mexico Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 89Mexico Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 90Mexico Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 91Mexico Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 92Mexico Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 93Mexico Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 94Mexico Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 95Rest of North America Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 96Rest of North America Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 97Rest of North America Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 98Rest of North America Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 99Rest of North America Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 100Rest of North America Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 101Rest of North America Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 102Rest of North America Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 103Rest of North America Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 104Rest of North America Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 105Rest of North America Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 106Rest of North America Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 107Rest of North America Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 108Rest of North America Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 109key information - Illumina, Inc.
TABLE 110Key Information - Becton, Dickinson and Company
TABLE 111Key Information - Genetic Analysis AS
TABLE 112Key Information - Microba Life Sciences Limited
TABLE 113Key Information -BioMe Oxford Ltd
TABLE 114Key Information - Viome Life Sciences, Inc.
TABLE 115Key Information - GoodGut S.L.U.
TABLE 116Key Information - Sun Genomics
TABLE 117Key Information - Origin Sciences Limited
TABLE 118Key Information - Decode Age

North America Microbiome Diagnostics Market Size, Share & Trends Analysis Report By Application, By Product, By Sample, By Technology, By End User, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents